Explore

Communities in English

Advertise on Engormix

Gut integrity, intestinal microbiota and intestinal barrier or the strategy for enhanced performance and reduced medication and ZnO

Published: August 14, 2018
By: Dr. Milena Sevastiyanova
Gut integrity, intestinal microbiota and intestinal barrier or the strategy for enhanced performance and reduced medication and ZnO - Image 1
Abstract
The gut carries an important responsibility in selecting what can be absorbed and what should remain outside the body. To put this in the right perspective, it is important to note that the surface of the intestinal tract is 300 times the size of the surface of the skin.
Post-weaning diarrhoea (PWD) causes mortality and morbidity in pig production and is a reason for regular antibiotic treatment. Two concerns are related with PWD:
  • Lost profit due to mortality, lower average daily weight gain (ADWG), additional medication costs.
  • Recommendation of European Medicines Agency for reducing the usage of Colistin related to the risk of antimicrobial resistance.
To reduce (stop) antibiotics for PWD and to enhance performance is crucial to understand and to support the complex mechanism that maintains the gut health. This trial investigated the effectiveness of in feed combination of short and medium chain fatty acids, plant extracts and essential oils (Lumance®, Innovad®, Belgium) on PWD and ADWG in a commercial farm in Bulgaria.
Introduction
The gut integrity and microbiota appear to be the key for a mechanism that maintains the gut health. Supporting the intestinal barrier to decrease the risk of infectious and inflammation is crucial. Tight junctions have a major task to avoid paracellular passage of undesired substances from the lumen to the inside of the body. Different factors could have a negative impact on the tight junctions, leading to “leaking gut” which resulting further in cell damage, production of “Reactive Oxygen Species” (ROS) and activation of the immune system. This automatically unlocks the production of inflammatory cytokines. Their neutralisation will consume significant amounts of nutrients, leading to reduced growth and increased FCR. It is documented that butyrate enhances the intestinal barrier by facilitating tight junction assembly and regulating of immune cells function (1,2). Butyric acid contributed with plant extracts rich alkaloids show strong anti-inflammatory action, improved gain and FCR. Butyrate stimulates epithelial cell proliferation ensuring larger absorptive surface and improved feed utilisation. It preserves villus length and its role at weaning is highly valuable when the intestine increases three times faster than the whole body mass.
The secreted by intestinal epithelium Host defence peptides are a critical component of the innate immunity. Butyrate upregulates endogenous HDP and enhance disease resistance in piglets (3). It increases glutathione (4) and so is indirectly active against ROS.
Butyrate has strong antibacterial activity, but mono-esterified butyrins is several times stronger against E.coli and Salmonella compared to butyric acid. Combination of esterified butyrins and medium chain fatty acids (capric) significantly improves the performance of the pigs and laurin is highly effective against E.coli, Salmonella sp. and Clostridium perfringens (5).
The broad spectrum of intestinal microbiota lives in direct symbiosis with the host. They provide energy to the intestinal wall, prevent colonisation by pathogenic bacteria and help to maintain the intestinal immune system.
Materials and Methods
In two trials (T1 and T2), a treatment of 400 piglets each was compared with a control group of 400 piglets. The treatments in T1 and T2 included Lumance® at respectively 1,5 kg/T and 1 kg/T in the feed from the day of weaning (30 days) for 20 days and ZnO for 20 days 3000 ppm and 2000 ppm respectively starting from weaning. The control group for both trials included Colistin (12% ) in the feed at 2 kg/T for 10 days from weaning and ZnO, 3000 ppm for 20 days from weaning. PWD and ADWG were monitored from D30 till D94.
Results:
No symptoms of PWD were observed in none of the groups during both trials. ADWG in growing phase were respectively: control groups - 610 g and 620 g and Lumance® groups - 675 g in T1 and 709 g. The pigs of groups T1 and T2 achieve slaughter weight 7 days earlier compare to control groups. At the end groups T1 and T2 shows 7 days earlier to slaughter (150 days) at an average weight of 107 kg.
 
Gut integrity, intestinal microbiota and intestinal barrier or the strategy for enhanced performance and reduced medication and ZnO - Image 2
 
Discussion:
Based on the above, we can conclude that a high status of intestinal health based on a combination of strong tight junctions, long and healthy villi, balanced the microflora, low levels of ROS and inflammatory cytokines ensure the possibility to stop antibiotic treat-ments and improving the performance. Complex formula of Lumance® is an effective to replace Colistin and reduce ZnO for preventing PWD, while having a positive effect on ADWG of the treated animals.
Related topics:
Authors:
Dr. Milena Sevastiyanova
Innovad
Influencers who recommended :
Juarez Donzele
Recommend
Comment
Share
Heidi Hall
Anpario
6 de diciembre de 2019
Dear Dr. Milena Sevastiyanova, Thank you for the article. I feel that the conclusion that the product Luminance can replace Colistin has not been shown effectively in this trial. As the PWD symptoms were not seen the use of colistin was unnecessary and so it cannot be concluded that the product provided an effective replacement. Also there are no stats or negative control in this study so it is hard to know if a treatment with neither product would perform equally well.
Recommend
Reply
Juarez Donzele
Universidade Federal de Viçosa - UFV
Universidade Federal de Viçosa - UFV
12 de septiembre de 2018

Good story, with consistent fundamentals. However, I have some doubts about what I would like to clarify. - There is no doubt about the bactericidal action of short chain (acc) and medium chain (acm) acros. My question as a researcher is that normally the immune challenge of the animals in the experiment is appreciably less than the field level, in which case the acc and acm may prove as efficient as the antibiotic. Furthermore, in the farm, besides the possible difference in the immune challenge, other factors such as density of animals in the nursery cage, the availability of feeder and the mixture of animals from different litters, among other factors, may contribute to compromise the efficacy of the acrylics in replace the antibiotic or Zno.
I understand that antibiotic dysbiosis is a potential risk for piglets, considering that healthy microbiota is essential to ensure a good performance of the animals, which can be obtained using the acc and acm, the doubt, if I I did understand, is that in the case of replacing the antíbiotico by acc and acm, other details of management should be observed in order to reduce the stress level of the animals.

Recommend
Reply
Profile picture
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Pig Industry
Sriraj Kantamneni
Sriraj Kantamneni
Cargill
Global Business Technology Director
United States
Francis Simard
Francis Simard
Trouw Nutrition
Agr., M. Sc. / Nutrition and Development Director at Trouw Nutrition Canada
United States
Tom Frost
Tom Frost
dsm-Firmenich
Director of Innovation & Application
United States
Join Engormix and be part of the largest agribusiness social network in the world.